- Investing Ideas
- Swiss Pharmaceuticals & Biotech Stable Growth Stocks
Swiss Pharmaceuticals & Biotech Stable Growth Stocks
Results
3
0 new
3 companies
Bachem Holding
Market Cap: CHF 5.6b
Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
BANB
CHF 74.85
7D
0.3%
1Y
9.3%
Galderma Group
Market Cap: CHF 39.5b
Operates as a dermatology company worldwide.
GALD
CHF 169.60
7D
-3.6%
1Y
25.4%
Lonza Group
Market Cap: CHF 39.6b
Operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 565.80
7D
-1.7%
1Y
1.0%